We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.43B
AUM Growth
+$187M
Cap. Flow
-$93.9M
Cap. Flow %
-2.74%
Top 10 Hldgs %
15.47%
Holding
218
New
12
Increased
43
Reduced
121
Closed
7

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$14.8M
2
CGNX icon
Cognex
CGNX
+$12.2M
3
AZTA icon
Azenta
AZTA
+$11.9M
4
XLRN
Acceleron Pharma
XLRN
+$10.7M
5
ABCO
Advisory Board Co
ABCO
+$9.22M

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$27.8M
2
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$21.8M
3
CSGP icon
CoStar Group
CSGP
+$12.3M
4
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$10.6M
5
EXAS
Exact Sciences
EXAS
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 28.94%
2 Healthcare 15.18%
3 Consumer Discretionary 14.11%
4 Industrials 12.3%
5 Communication Services 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTCT
26
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$36.5M 1.06%
993,778
-232,791
-19% -$7.63M
BLOX
27
DELISTED
Infoblox Inc
BLOX
$36.1M 1.05%
1,787,500
+208,600
+13% +$3.49M
KMT icon
28
Kennametal
KMT
$2.52B
$35.4M 1.03%
988,363
– –
DECK icon
29
Deckers Outdoor
DECK
$13.3B
$34.4M 1%
2,266,200
-320,400
-12% -$4.88M
PTC icon
30
PTC
PTC
$16B
$33.2M 0.97%
906,170
-44,000
-5% -$1.63M
BIO icon
31
Bio-Rad Laboratories Class A
BIO
$9.42B
$32.4M 0.95%
268,934
– –
MTD icon
32
Mettler-Toledo International
MTD
$28.6B
$32M 0.93%
105,750
– –
ULTI
33
DELISTED
Ultimate Software Group Inc
ULTI
$30.6M 0.89%
208,709
-39,000
-16% -$5.66M
ZLTQ
34
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$30.2M 0.88%
1,082,410
-301,039
-22% -$7.84M
VRTU
35
DELISTED
Virtusa Corporation
VRTU
$29.9M 0.87%
718,503
+39,260
+6% +$1.53M
KAMN
36
DELISTED
Kaman Corp
KAMN
$29.3M 0.86%
730,796
-7,662
-1% -$307K
MLNX
37
DELISTED
Mellanox Technologies, Ltd.
MLNX
$28.2M 0.82%
660,900
-700
-0.1% -$30.4K
FNSR
38
DELISTED
Finisar Corp
FNSR
$28.2M 0.82%
1,451,700
+10,500
+0.7% +$180K
FDS icon
39
Factset
FDS
$10.2B
$28.1M 0.82%
199,650
– –
IRBT
40
DELISTED
iRobot
IRBT
$28M 0.82%
806,761
+111,672
+16% +$3.83M
FRAN
41
DELISTED
Francesca's Holdings Corporation
FRAN
$28M 0.82%
139,725
-9,125
-6% -$1.46M
AUXL
42
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$27.9M 0.82%
812,380
-160,000
-16% -$5.22M
TYPE
43
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$26.9M 0.79%
933,258
+126,981
+16% +$3.56M
SLAB icon
44
Silicon Laboratories
SLAB
$7.23B
$26.9M 0.78%
564,588
-45,832
-8% -$2.02M
GIMO
45
DELISTED
Gigamon Inc.
GIMO
$26M 0.76%
1,464,300
+145,700
+11% +$2.06M
CHDN icon
46
Churchill Downs
CHDN
$6.12B
$25.9M 0.76%
1,630,200
-167,400
-9% -$2.72M
ARUN
47
DELISTED
ARUBA NETWORKS, INC.
ARUN
$25.4M 0.74%
1,397,200
+13,400
+1% +$267K
TER icon
48
Teradyne
TER
$59.3B
$24.9M 0.73%
1,259,280
-8,900
-0.7% -$168K
ISIL
49
DELISTED
Intersil Corp
ISIL
$24.8M 0.72%
1,713,395
-1,800
-0.1% -$23.9K
TIVO
50
DELISTED
TIVO INC
TIVO
$24.6M 0.72%
2,076,820
-251,500
-11% -$3.14M
1
2
3 4 5

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Granahan Investment Management held 218 positions worth $3.43B, up 5.8% from $3.24B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Granahan Investment Management's Q4 2014 filing shows 12 new, 43 increased, 121 reduced and 7 closed positions. Its largest new stake was Azenta: 1,023,321 shares worth $13M. The largest sale was West Pharmaceutical, an estimated $27.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Granahan Investment Management's largest Q4 2014 buy was Azenta: 1,023,321 shares worth $13M.
  • Granahan Investment Management added most to Axon Enterprise in Q4 2014, an estimated $14.8M increase.
  • Granahan Investment Management's biggest Q4 2014 reduction was West Pharmaceutical, cutting an estimated $27.8M.
  • Granahan Investment Management fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $21.8M.
  • Granahan Investment Management's ten largest holdings make up 15% of its $3.43B portfolio in Q4 2014.
  • Granahan Investment Management opened 12 new positions and closed 7 in Q4 2014.
  • Granahan Investment Management's portfolio value rose 5.8% quarter-over-quarter to $3.43B.

Based on Granahan Investment Management's 13F filing for Q4 2014, filed 20 Jan 2015.